[Informed consent in the framework of biomedical research: a survey].
Inquiry on the quality and steps taken to obtain informed consents for biomedical research projects, based on the cases of 39 patients coming from 15 different projects with immediate therapeutic goals and 16 healthy subjects coming from 4 different projects without immediate therapeutic goals. Comparison between observed reality and the more or less demanding norms that were recommended. We noted a much bigger gap (therefore a consent actually informed in a lesser way) in the group of patients than in the group of healthy subjects. Explanatory hypotheses: the healthy subjects' higher social and cultural level, but also the investigators' difficulty and comprehensible discomfort to integrate, with respect to the patient, the essentially different and possibly contradictory points of view of scientific research and medical care; the "double market" notion.